A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese Adults
Status:
Active, not recruiting
Trial end date:
2023-02-10
Target enrollment:
Participant gender:
Summary
To evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and
immunogenicity of AZD7442 in Healthy Chinese Adults. vs. placebo